![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 40638 |
FusionGeneSummary for UBXN1_BSCL2 |
![]() |
Fusion gene information | Fusion gene name: UBXN1_BSCL2 | Fusion gene ID: 40638 | Hgene | Tgene | Gene symbol | UBXN1 | BSCL2 | Gene ID | 51035 | 26580 |
Gene name | UBX domain protein 1 | BSCL2, seipin lipid droplet biogenesis associated | |
Synonyms | 2B28|SAKS1|UBXD10 | GNG3LG|HMN5|PELD|SPG17 | |
Cytomap | 11q12.3 | 11q12.3 | |
Type of gene | protein-coding | protein-coding | |
Description | UBX domain-containing protein 1SAPK substrate protein 1UBA/UBX 33.3 kDa protein | seipinBerardinelli-Seip congenital lipodystrophy 2 (seipin)Bernardinelli-Seip congenital lipodystrophy type 2 protein | |
Modification date | 20180522 | 20180525 | |
UniProtAcc | Q04323 | Q96G97 | |
Ensembl transtripts involved in fusion gene | ENST00000294119, ENST00000301935, ENST00000533000, ENST00000529640, ENST00000524762, | ENST00000405837, ENST00000433053, ENST00000278893, ENST00000360796, ENST00000403550, ENST00000407022, ENST00000421906, ENST00000537604, | |
Fusion gene scores | * DoF score | 3 X 2 X 2=12 | 9 X 5 X 7=315 |
# samples | 3 | 9 | |
** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(9/315*10)=-1.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: UBXN1 [Title/Abstract] AND BSCL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | UBXN1 | GO:0031397 | negative regulation of protein ubiquitination | 20351172 |
Hgene | UBXN1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 20351172 |
Hgene | UBXN1 | GO:1903094 | negative regulation of protein K48-linked deubiquitination | 21135095 |
Hgene | UBXN1 | GO:2000157 | negative regulation of ubiquitin-specific protease activity | 21135095 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-AO-A129-01A | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000294119 | ENST00000405837 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000433053 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000278893 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000360796 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000403550 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000407022 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000294119 | ENST00000421906 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5CDS-intron | ENST00000294119 | ENST00000537604 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000405837 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000433053 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000278893 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000360796 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000403550 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000407022 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000301935 | ENST00000421906 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5CDS-intron | ENST00000301935 | ENST00000537604 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000405837 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000433053 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000278893 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000360796 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000403550 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000407022 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000533000 | ENST00000421906 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5CDS-intron | ENST00000533000 | ENST00000537604 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000405837 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000433053 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000278893 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000360796 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000403550 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000407022 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
In-frame | ENST00000529640 | ENST00000421906 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5CDS-intron | ENST00000529640 | ENST00000537604 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000405837 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000433053 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000278893 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000360796 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000403550 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000407022 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-3CDS | ENST00000524762 | ENST00000421906 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
5UTR-intron | ENST00000524762 | ENST00000537604 | UBXN1 | chr11 | 62444990 | - | BSCL2 | chr11 | 62460269 | - |
Top |
FusionProtFeatures for UBXN1_BSCL2 |
![]() |
Hgene | Tgene |
UBXN1 | BSCL2 |
Ubiquitin-binding protein that plays a role in themodulation of innate immune response. Blocks both the RIG-I-likereceptors (RLR) and NF-kappa-B pathways. Following viralinfection, UBXN1 is induced and recruited to the RLR componentMAVS. In turn, interferes with MAVS oligomerization, and disruptsthe MAVS/TRAF3/TRAF6 signalosome. This function probably serves asa brake to prevent excessive RLR signaling (PubMed:23545497).Interferes with the TNFalpha-triggered NF-kappa-B pathway byinteracting with cellular inhibitors of apoptosis proteins (cIAPs)and thereby inhibiting their recruitment to TNFR1(PubMed:25681446). Prevents also the activation of NF-kappa-B byassociating with CUL1 and thus inhibiting NF-kappa-B inhibitoralpha/NFKBIA degradation that remains bound to NF-kappa-B(PubMed:28152074). Interacts with the BRCA1-BARD1 heterodimer andregulates its activity. Specifically binds 'Lys-6'-linkedpolyubiquitin chains. Interaction with autoubiquitinated BRCA1leads to the inhibition of the E3 ubiquitin-protein ligaseactivity of the BRCA1-BARD1 heterodimer (PubMed:20351172).Component of a complex required to couple deglycosylation andproteasome-mediated degradation of misfolded proteins in theendoplasmic reticulum that are retrotranslocated in the cytosol.{ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:23545497,ECO:0000269|PubMed:25681446, ECO:0000269|PubMed:28152074}. | Is a regulator of lipid catabolism essential foradipocyte differentiation. May also be involved in the centralregulation of energy homeostasis (By similarity). Necessary forcorrect lipid storage and lipid droplets maintenance; may play atissue-autonomous role in controlling lipid storage in adipocytesand in preventing ectopic lipid droplet formation in non-adiposetissues. {ECO:0000250, ECO:0000269|PubMed:19278620,ECO:0000269|PubMed:21533227}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000294119 | - | 7 | 8 | 87_172 | 217 | 313 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000301935 | - | 7 | 9 | 87_172 | 217 | 298 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000294119 | - | 7 | 8 | 2_42 | 217 | 313 | Domain | UBA |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000301935 | - | 7 | 9 | 2_42 | 217 | 298 | Domain | UBA |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000278893 | - | 3 | 10 | 264_398 | 146 | 253 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000360796 | - | 3 | 11 | 264_398 | 210 | 463 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000403550 | - | 3 | 11 | 264_398 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000407022 | - | 3 | 11 | 264_398 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000421906 | - | 3 | 11 | 264_398 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000433053 | - | 4 | 12 | 264_398 | 210 | 463 | Topological domain | Cytoplasmic |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000278893 | - | 3 | 10 | 243_263 | 146 | 253 | Transmembrane | Helical |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000360796 | - | 3 | 11 | 243_263 | 210 | 463 | Transmembrane | Helical |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000403550 | - | 3 | 11 | 243_263 | 146 | 399 | Transmembrane | Helical |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000407022 | - | 3 | 11 | 243_263 | 146 | 399 | Transmembrane | Helical |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000421906 | - | 3 | 11 | 243_263 | 146 | 399 | Transmembrane | Helical |
Tgene | >BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000433053 | - | 4 | 12 | 243_263 | 210 | 463 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000294119 | - | 7 | 8 | 211_293 | 217 | 313 | Domain | UBX |
Hgene | >UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000301935 | - | 7 | 9 | 211_293 | 217 | 298 | Domain | UBX |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000278893 | - | 3 | 10 | 1_26 | 146 | 253 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000278893 | - | 3 | 10 | 48_242 | 146 | 253 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000360796 | - | 3 | 11 | 1_26 | 210 | 463 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000360796 | - | 3 | 11 | 48_242 | 210 | 463 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000403550 | - | 3 | 11 | 1_26 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000403550 | - | 3 | 11 | 48_242 | 146 | 399 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000407022 | - | 3 | 11 | 1_26 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000407022 | - | 3 | 11 | 48_242 | 146 | 399 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000421906 | - | 3 | 11 | 1_26 | 146 | 399 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000421906 | - | 3 | 11 | 48_242 | 146 | 399 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000433053 | - | 4 | 12 | 1_26 | 210 | 463 | Topological domain | Cytoplasmic |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000433053 | - | 4 | 12 | 48_242 | 210 | 463 | Topological domain | Lumenal |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000278893 | - | 3 | 10 | 27_47 | 146 | 253 | Transmembrane | Helical |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000360796 | - | 3 | 11 | 27_47 | 210 | 463 | Transmembrane | Helical |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000403550 | - | 3 | 11 | 27_47 | 146 | 399 | Transmembrane | Helical |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000407022 | - | 3 | 11 | 27_47 | 146 | 399 | Transmembrane | Helical |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000421906 | - | 3 | 11 | 27_47 | 146 | 399 | Transmembrane | Helical |
Tgene | BSCL2 | chr11:62444990 | chr11:62460269 | ENST00000433053 | - | 4 | 12 | 27_47 | 210 | 463 | Transmembrane | Helical |
Top |
FusionGeneSequence for UBXN1_BSCL2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for UBXN1_BSCL2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
UBXN1 | ASF1B, CDK4, USP32, BABAM1, WDR20, VCP, NPLOC4, UFD1L, CUL1, CUL2, CUL3, UBR1, HIF1A, ALPP, VCPIP1, KLHL12, KLHL22, KBTBD7, BTBD2, DDB1, AMFR, UBR2, UBR4, PJA2, BIRC3, RLIM, UBR5, UBE3A, HUWE1, UBE4B, BRCA1, BARD1, UBC, HOMER2, SPRTN, RPA1, UBE2V2, USP9X, SSSCA1, ZFYVE19, UNC45A, UBQLN4, UFC1, VPS4B, KIAA1598, CLNS1A, UNK, TWF1, USP34, TTC1, ZPR1, ATP6V1A, SEC22B, PIPSL, NPTN, RPA3, IGBP1, VTA1, SULT1A1, CSE1L, UBQLN1, TXNDC5, S100A16, AHCYL1, UFM1, DNAJB11, VAMP2, RPA2, UBE2C, UBE2L3, CD81, BASP1, CTPS1, HMGB3, MCTS1, NSFL1C, PAFAH1B1, PROSC, TUBB2A, TUFM, TXNRD1, CAPN2, DENR, HK1, HSPA5, STK26, PLAA, TRNT1, TWF2, YWHAE, MAVS, PLA2G4A, UBE2I, FAM189A2, UBXN1, TRIM39, NXF1, PSMD4, USP47, BTBD9, MARCH7, FAM115A, KCTD10, TNFAIP1, MID2, SHKBP1, BTBD1, PSMC3, ACAT2, PRPF19, SPDL1, TAGLN3, UBE2A, BIRC2, MCM2, BAG6, PPP1R7, PRPS2, PRPSAP2, GET4, PSMA1, UBL4A, FAF1, FAF2, MAGED1, MYO6, PPP1CB, SQSTM1, UBXN7, DSC1, DSG1, GAR1, HDAC8, JUP, TRA, DUSP6, EMILIN1, YAF2, CCDC102B, AARSD1, A1BG, KLHL10, KLRG2, CDK5R1 | BSCL2 | TMEM19, SMIM3, USE1, CANX, NSG1, PLEKHF2, SMLR1, TSPAN5, ICAM2, IL20RB, MCOLN3, TSPAN17, GABRE, TMEM25, KIAA2013, HDGFRP3, DNAJC13, POM121, POM121C, SLC35B2, ZDHHC17, SC5D, GPR89A, CD47, SLC39A3, TMPPE, CHPT1, SCAMP2, ATAD1, ERGIC3, GLRA2, GABRA6, GABRG2, ASIC4, UPK1A, HTR3A, EBP, B4GAT1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000294119 | - | 7 | 8 | 43_297 | 217 | 313 | BRCA1 |
Hgene | UBXN1 | chr11:62444990 | chr11:62460269 | ENST00000301935 | - | 7 | 9 | 43_297 | 217 | 298 | BRCA1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for UBXN1_BSCL2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for UBXN1_BSCL2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | UBXN1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | BSCL2 | C2931276 | Spastic paraplegia 17 | 3 | CTD_human;ORPHANET;UNIPROT |
Tgene | BSCL2 | C1720863 | Congenital Generalized Lipodystrophy Type 2 | 2 | UNIPROT |
Tgene | BSCL2 | C0023787 | Lipodystrophy | 1 | CTD_human;HPO |
Tgene | BSCL2 | C0028960 | Oligospermia | 1 | CTD_human |
Tgene | BSCL2 | C0034012 | Delayed Puberty | 1 | CTD_human |
Tgene | BSCL2 | C0403823 | Asthenozoospermia | 1 | CTD_human |
Tgene | BSCL2 | C0525045 | Mood Disorders | 1 | PSYGENET |